IN BRIEF: Jazz Pharma accuses Avadel of infringing Xyrem patents - Reuters

2:49pm PDT - May 13th, 2021    jazz - Reuters

Jazz Pharmaceuticals Inc accused Avadel Pharmaceuticals PLC of infringing five patents related to its blockbuster narcolepsy drug Xyrem in response to Avadel's plans to make its own narcolepsy drug, in a complaint entered Thursday in Delaware federal court.